Misetionamide

Advertisement

cGxPJobs Banner

Persevere Therapeutics Doses First Patient in MIROC-1

CHESTERBROOK, Pa. — September 24, 2026 Persevere Therapeutics, Inc. announced that the first patient has been enrolled and treated...

By cGxPwire Editor
September 26, 2026

Read More

Advertisement

cGxPJobs

Directory